Warp: Gerald has a tendency to talk big about cata

Warp: Gerald has a tendency to talk big about catalysts in the future, but when that time arrives he abandons talking about it because he has moved on to other catalysts even further into the future.

What ever happened to the "codes" Gerald talked about in January?
What ever happened to the end of summer LymPro partnership?
What ever happened to Lympro Revenue guidance? (Jason's 1 million/2015?)
What ever happened to being on target to up list in Q4?
What ever happened to all the value increasing catalysts in Q4?

Why would you get excited about Gerald's nebulous talk of a diagnostic spin off in 2015 when he doesn't even address the 1 million revenue estimate by Napodano? What good does a spun off division do if there is no revenue?

It's all "Geraldspeak." Today's ESS catalyst is nice and may add value to us in a couple of years....but that's a long way off. That's why it was greeted the way it was by the market today.

Gerald needs to come clean about LymPro. Why do we hear about every Tom, Dick, and Harry AD blood test coming on in 2 to 4 years, but no one knows anything about LymPro? Where is the clamor for LyMpro that is 1 month away from launching? Where is the excitement for it by the market? It's missing in action.